We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Small molecule might alleviate acetaminophen-induced liver damage
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Small molecule might alleviate acetaminophen-induced liver damage
Small molecule might alleviate acetaminophen-induced liver damage
Health

Small molecule might alleviate acetaminophen-induced liver damage

Last updated: August 18, 2025 10:19 am
Editorial Board Published August 18, 2025
Share
SHARE

Credit score: Unsplash/CC0 Public Area

Acetaminophen is without doubt one of the commonest painkillers and is present in lots of of various medicines. Whereas protected at really useful doses, acetaminophen overdose is the main explanation for acute liver damage within the U.S.

Now, researchers suggest {that a} new molecule has the potential to deal with acetaminophen-induced liver damage (AILI) and different inflammatory circumstances. They performed a small-scale mouse trial and located that the brand new compound decreased AILI-caused liver irritation and prevented liver harm.

Jannatun Nayem Namme, a graduate scholar at Virginia Commonwealth College, introduced her group’s outcomes on the fall assembly of the American Chemical Society (ACS Fall 2025) held Aug. 17–21.

Most acetaminophen overdoses are unintentional, usually attributable to individuals unintentionally consuming a number of merchandise containing the painkiller or misinterpreting dosage.

After taking a really useful quantity of acetaminophen, an individual’s liver converts a small share of it right into a poisonous molecule known as N-acetyl-p-benzoquinone imine (NAPQI). Usually, the liver can shortly metabolize NAPQI right into a non-toxic type. But when an individual takes an excessive amount of acetaminophen, NAPQI builds up and causes irreversible cell harm, resulting in liver damage or dying.

At present, N-acetylcysteine is the one drug obtainable to deal with AILI, and it have to be administered inside eight hours of overdose.

To develop novel therapies for inflammatory circumstances, corresponding to AILI, and neurodegenerative circumstances, Namme and her colleagues beforehand centered on small molecules that cut back the exercise of inflammation-causing proteins, often known as inflammasomes. Inflammasomes are additionally concerned in pyroptosis, a sort of mobile dying related to AILI.

Whereas creating inflammasome inhibitors, the researchers seen that a few of the compounds they created might goal a particular inflammatory protein known as gasdermin D (GSDMD). GSDMD is concerned in pyroptosis.

Namme and the group synthesized a number of completely different GSDMD-inhibiting compounds and examined them for his or her capacity to bind to GSDMD. They found that one small molecule, which they labeled YM81, selectively binds to and inhibits GSDMD from initiating pyroptosis.

Subsequent, the researchers handled 5 mice with AILI utilizing YM81 and in contrast them to 10 mice given a placebo. They monitored the extent of liver harm within the animals 17 hours after the acetaminophen overdose.

In comparison with the placebo group, mice handled with YM81 had considerably decrease ranges of alanine transaminase and aspartate transaminase, two liver damage biomarkers. These outcomes point out that the YM81 therapy helped lower liver irritation by inhibiting GSDMD.

Shijun Zhang, the examine’s principal investigator, says that YM81 is within the early phases of drug improvement. “In the future, we will focus on optimizing YM81 to increase its potency, safety and stability, in addition to exploring its therapeutic potential in additional animal models,” he says.

Namme provides that GSDMD inhibitors like YM81 have the potential to deal with different inflammatory circumstances.

“GSDMD is a common protein involved in multiple inflammatory and neurodegenerative diseases, such as arthritis, sepsis and gout,” she says. “Targeting GSDMD could offer a therapeutic strategy to reduce the inflammation and damage from multiple diseases and causes.”

Extra info:
Growth of a novel GSDMD inhibitor for the therapy of acetaminophen-induced liver damage. acs.digitellinc.com/stay/35/session/569849

Offered by
American Chemical Society

Quotation:
Small molecule might alleviate acetaminophen-induced liver damage (2025, August 18)
retrieved 18 August 2025
from https://medicalxpress.com/information/2025-08-small-molecule-alleviate-acetaminophen-liver.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:acetaminopheninducedalleviateinjuryLiverMoleculesmall
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Scott Wedgewood stops 25 pictures within the Avalanche’s 4-0 win over the Devils
Sports

Scott Wedgewood stops 25 pictures within the Avalanche’s 4-0 win over the Devils

Editorial Board December 9, 2024
27 must-see panels at San Diego Comedian-Con
Maternal air air pollution publicity worsens bronchial asthma severity for offspring
If You Make $90,000 a 12 months, Right here’s How A lot Home You Can Afford: All You Want To Know
Wish to play video games below the celebrities? The Music Heart is popping into an outside arcade

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?